compound introduction
Cabamiquine (DDD107498) succinate is a potent and orally active antimalarial agent, inhibits multiple life-cycle stages of the parasite , with an EC 50 of 1 nM against P. falciparum 3D7. Cabamiquine succinate inhibits protein synthesis by targeting eEF2/CaMKIII , with an EC 50 of 2 nM for WT- Pf eEF2 In Vivo Cabamiquine (DDD107498) exhibits an ED 90 of 0.57 mg/kg after a single oral dose in mice infected with the rodent parasite P. berghei . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:CaMK III Plasmodium
